Gujarat Themis Biosyn Stock Performance
|
|
|
Gujarat Themis Biosyn Company background
Founded in: 1981
Managing director: Sachin D Patel
Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG) a unique consortium of five competing drug companies Themis Medicare Ltd., Kopran Ltd., Anant Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, it was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corporation, South Korea, brought in technology and finance for running GTBL.During 199596 the paidup share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interst term loan. During the year 201920, installed capacity of rifamysinS was increased to 90 mtpa and expansion of rifampicin was achieved to the maximum capacity of 120 mtpa. It also commenced operations of its new pharmaceutical division and launched a wide range of antituberculosis products and other antibiotics in 2022.The Company is presently in the business of manufacturing and sale of raw material by fermentation process.
As of 19 Aug, 2025, Gujarat Themis Biosyn share price is ₹362.3. The stock opened at ₹355.7 and had closed at ₹362 the previous day. During today’s trading session, Gujarat Themis Biosyn share price moved between ₹353.90 and ₹369.00, with an average price for the day of ₹361.45. Over the last 52 weeks, the stock has recorded a low of ₹208.00 and a high of ₹405.00. In terms of performance, Gujarat Themis Biosyn share price has increased by 70.7% over the past six months and has increased by 48.40% over the last year.
Gujarat Themis Biosyn Fundamental
Market Cap (in crs)
3,954.89
Face Value
1
Turnover (in lacs)
447.97
Key Metrics
Qtr Change %
88.35% Gain from 52W Low
5.8
Dividend yield 1yr %
0
Gujarat Themis Biosyn Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
361.75
Current Price
5Day EMA
360.10
10Day EMA
360.40
12Day EMA
360.80
20Day EMA
361.00
26Day EMA
359.90
50Day EMA
350.90
100Day EMA
334.10
200Day EMA
316.80
5Day SMA
360.60
10Day SMA
356.40
20Day SMA
365.90
30Day SMA
363.20
50Day SMA
353.90
100Day SMA
324.60
150Day SMA
307.50
200Day SMA
310.40
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 80747 Rs | 132729 Rs |
Week Rs | 58165 Rs | 117913 Rs |
Month Rs | 131022 Rs | 241008 Rs |
Resistance & Support
361.43
Pivot
Resistance
First Resistance
368.87
Second Resistance
375.43
Third Resistance
382.87
Support
First Support
354.87
Second support
347.43
Third Support
340.87
Relative Strength Index
51.51
Money Flow Index
30.19
MACD
0.91
MACD Signal
2.60
Average True Range
17.07
Average Directional Index
22.74
Rate of Change (21)
-1.20
Rate of Change (125)
39.08
Gujarat Themis Biosyn Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
362.25 | 3,663.14 | 298.8 | 504.25 | 363.85 | 2.97% | -4.97% | -8.26% | 6.11% | 82.33% | 0.03% | 59.91 | 40.62 | 6.09 | |
763.90 | 3,868.09 | 603.8 | 1998 | 756.25 | 0.40% | 4.13% | -8.63% | -45.69% | 151.95% | 0.00% | 40.48 | 40.62 | 2.92 | |
3,789.09 | 1835 | 2974.95 | 2,283.60 | -0.05% | -8.63% | -1.09% | 7.88% | 223.27% | 1.05% | 36.59 | 40.62 | 7.14 | ||
176.96 | 4,410.90 | 117.35 | 240.7 | 175.64 | 1.14% | -6.20% | 17.40% | 11.88% | 60.18% | 0.00% | 235.27 | 40.62 | 3.87 | |
361.75 | 3,954.89 | 208 | 405 | 361.30 | 1.58% | -0.83% | 37,317.53% | 37,317.53% | 37,317.53% | 0.18% | 88.58 | 40.62 | 15.89 | |
268.00 | 4,224.52 | 161.21 | 307.98 | 263.15 | 10.98% | 3.50% | 20.94% | 56.80% | 125.20% | 0.00% | 0.00 | 40.62 | 1.04 |
Gujarat Themis Biosyn Share Price FAQs
What is Share Price of Gujarat Themis Biosyn ?
Gujarat Themis Biosyn share price is ₹361.75 in NSE and ₹361.40 in BSE as on 19/8/2025.
How has Gujarat Themis Biosyn shares performed in the past ?
Gujarat Themis Biosyn share price in the past 1-year return was 37317.52. The Gujarat Themis Biosyn share hit a 1-year low of Rs. 208 and a 1-year high of Rs. 405.
What is the market cap of Gujarat Themis Biosyn ?
The market cap of Gujarat Themis Biosyn is Rs. 3954.89 Cr. as of 19/8/2025.
What is the current P/E ratio of Gujarat Themis Biosyn ?
The PE ratios of Gujarat Themis Biosyn is 88.58 as of 19/8/2025.
What is the current PB ratio of Gujarat Themis Biosyn ?
The PB ratios of Gujarat Themis Biosyn is 15.89 as of 19/8/2025
What is the Mutual Fund shareholding in Gujarat Themis Biosyn ?
The Mutual Fund Shareholding in Gujarat Themis Biosyn was 1.16% at the end of 19/8/2025.
How to buy Gujarat Themis Biosyn shares?
You can easily buy Gujarat Themis Biosyn shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Gujarat Themis Biosyn ?
The 52-week high and low of Gujarat Themis Biosyn share price is ₹405 and ₹208 as of 19/8/2025.
Please be aware that Gujarat Themis Biosyn stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account